130 related articles for article (PubMed ID: 1545125)
1. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection.
Honda M; Yamamoto S; Cheng M; Yasukawa K; Suzuki H; Saito T; Osugi Y; Tokunaga T; Kishimoto T
J Immunol; 1992 Apr; 148(7):2175-80. PubMed ID: 1545125
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
Rubin LA; Kurman CC; Fritz ME; Biddison WE; Boutin B; Yarchoan R; Nelson DL
J Immunol; 1985 Nov; 135(5):3172-7. PubMed ID: 3930598
[TBL] [Abstract][Full Text] [Related]
3. Identification of a soluble IL-2 receptor beta-chain from human lymphoid cell line cells.
Honda M; Kitamura K; Takeshita T; Sugamura K; Tokunaga T
J Immunol; 1990 Dec; 145(12):4131-5. PubMed ID: 2258611
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases.
Honda M; Kitamura K; Mizutani Y; Oishi M; Arai M; Okura T; Igarahi K; Yasukawa K; Hirano T; Kishimoto T
J Immunol; 1990 Dec; 145(12):4059-64. PubMed ID: 2258606
[TBL] [Abstract][Full Text] [Related]
5. Preparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies.
Saito T; Yasukawa K; Suzuki H; Futatsugi K; Fukunaga T; Yokomizo C; Koishihara Y; Fukui H; Ohsugi Y; Yawata H
J Immunol; 1991 Jul; 147(1):168-73. PubMed ID: 2051018
[TBL] [Abstract][Full Text] [Related]
6. High levels of soluble interleukin 2 receptors released from human retrovirus-infected cells.
Honda M; Yamamoto N; Nagao S; Tokunaga T
Jpn J Cancer Res; 1987 Sep; 78(9):889-93. PubMed ID: 2889714
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
8. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
9. Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization.
Honda M; Kitamura K; Matsuda K; Yokota Y; Yamamoto N; Mitsuyasu R; Chermann JC; Tokunaga T
J Immunol; 1989 Jun; 142(12):4248-55. PubMed ID: 2566634
[TBL] [Abstract][Full Text] [Related]
10. Cytokine regulation of localized inflammation. Induction of activated B cells and IL-6-mediated polyclonal IgG and IgA synthesis in inflamed human gingiva.
Kono Y; Beagley KW; Fujihashi K; McGhee JR; Taga T; Hirano T; Kishimoto T; Kiyono H
J Immunol; 1991 Mar; 146(6):1812-21. PubMed ID: 2005380
[TBL] [Abstract][Full Text] [Related]
11. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
Jablonska E
Mediators Inflamm; 2002 Oct; 11(5):325-8. PubMed ID: 12467526
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
13. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
[TBL] [Abstract][Full Text] [Related]
14. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.
Hirata Y; Taga T; Hibi M; Nakano N; Hirano T; Kishimoto T
J Immunol; 1989 Nov; 143(9):2900-6. PubMed ID: 2681418
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro.
Nakajima T; Yamamoto S; Cheng M; Yasukawa K; Hirano T; Kishimoto T; Tokunaga T; Honda M
Jpn J Cancer Res; 1992 Apr; 83(4):373-8. PubMed ID: 1506271
[TBL] [Abstract][Full Text] [Related]
16. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
Jablonska E; Marcinczyk M
Mediators Inflamm; 2003 Jun; 12(3):179-83. PubMed ID: 12857602
[TBL] [Abstract][Full Text] [Related]
18. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies.
Liautard J; Gaillard JP; Mani JC; Montero-Julian F; Duperray C; Lu ZY; Jourdan M; Klein B; Brailly H; Brochier J
Eur Cytokine Netw; 1994; 5(3):293-300. PubMed ID: 7524715
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.
Arnold R; Humbert B; Werchau H; Gallati H; König W
Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169
[TBL] [Abstract][Full Text] [Related]
20. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
